Drug-induced nephrotoxicity and its biomarkers

Biomolecules and Therapeutics

Volumn 20, Issue 3, 2012, Pages 268-272

  Kim, Sun Young ^a   Moon, Aree ^a  

^a Duksung Women's University   (South Korea)

Author keywords

Assessment; Biomarker; Nephrotoxicity

Indexed keywords

ACICLOVIR; ADEFOVIR; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPHOTERICIN B; AMPICILLIN; ANALGESIC AGENT; ANGIOTENSIN RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; CISPLATIN; CLUSTERIN; COLLAGEN TYPE 4; CYCLOSPORIN; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSCARNET; GENTAMICIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; KIDNEY INJURY MOLECULE 1; LITHIUM; MITOMYCIN C; NEUTROPHIL GELATINASE ASSOCIATED LIPOCALIN; NONSTEROID ANTIINFLAMMATORY AGENT; OSTEOPONTIN; PUROMYCIN; RIFAMPICIN; SEVOFLURANE;

DRUG ABUSE; DRUG SAFETY; ENZYME ACTIVITY; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HUMAN; INTERSTITIAL NEPHRITIS; KIDNEY BLOOD FLOW; KIDNEY DISEASE; KIDNEY INJURY; KIDNEY TUBULE CELL; NEPHROTOXICITY; PROTEINURIA; REVIEW; RHABDOMYOLYSIS; THROMBOTIC THROMBOCYTOPENIC PURPURA;

EID: 84862703179     PISSN: 19769148     EISSN: 20054483     Source Type: Journal    
DOI: 10.4062/biomolther.2012.20.3.268     Document Type: Review

References (58)

1. Alchi, B., Nishi, S., Kondo, D., Kaneko, Y., Matsuki, A., Imai, N., Ueno M., Iguchi, S., Sakatsume, M., Narita, I., Yamamoto, T. and Gejyo, F. (2005) Osteopontin expression in acute renal allograft rejection. Kidney Int. 67, 886-896.
2. Bailly, V., Zhang, Z., Meier, W., Cate, R., Sanicola, M. and Bonventre, J. V. (2002) Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 277, 39739-39748.
3. Baron, S., Tyring, S. K., Fleischmann, W. R. Jr., Coppenhaver, D. H., Niesel, D. W., Klimpel, G. R., Stanton, G. J. and Hughes, T. K. (1991) The interferons. Mechanisms of action and clinical applications. JAMA 266, 1375-1383.
4. Bernard, A. M., Vyskocil, A. A., Mahieu, P. and Lauwerys, R. R. (1987) Assessment of urinary retinol-binding protein as an index of proximal tubular injury. Clin. Chem. 33, 775-779.
5. Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P. and Dieterle, F. (2010) Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol. 28, 436-440.
6. Borregaard, N., Sehested, M., Nielsen, B. S., Sengeløv, H. and Kjeldsen, L. (1995) Biosynthesis of granule proteins in normal human bone marrow cells. Gelatinase is a marker of terminal neutrophil differentiation. Blood 85, 812-817.
7. Coco, T. J. and Klasner, A. E. (2004) Drug-induced rhabdomyolysis. Curr. Opin. Pediatr. 16, 206-210.
8. Conti, M., Moutereau, S., Zater, M., Lallali, K., Durrbach, A., Manivet, P., Eschwège, P. and Loric, S. (2006) Urinary cystatin C as a specific marker of tubular dysfunction. Clin. Chem. Lab. Med. 44, 288-291.
9. Donovan, K. L., Coles, G. A. and Williams, J. D. (1994) An ELISA for the detection of type IV collagen in human urine--application to patients with glomerulonephritis. Kidney Int. 46, 1431-1437.
10. Emeigh Hart, S. G. (2005) Assessment of renal injury in vivo. J. Pharmacol. Toxicol. Methods 52, 30-45.
11. Ferguson, M. A., Vaidya, V. S. and Bonventre, J. V. (2008) Biomarkers of nephrotoxic acute kidney injury. Toxicology 245, 182-193.
12. Finn, W. and Porter, G. (2003) Urinary biomarkers and nephrotoxicity. Clinical Nephrotoxins (2nd ed), pp. 621-655. Kluwer Academic Publishers Massachusetts.
13. Fored, C. M., Ejerblad, E., Lindblad, P., Fryzek, J. P., Dickman, P. W., Signorello, L. B., Lipworth, L., Elinder, C. G., Blot, W. J., McLaughlin, J. K., Zack, M. M. and Nyrén, O. (2001) Acetaminophen, aspirin, and chronic renal failure. N. Engl. J. Med. 345, 1801-1808.
14. Galley, H. F. (2000) Can acute renal failure be prevented? J. R. Coll. Surg. Edinb. 45, 44-50.
15. Guder, W.G. and Hoffmann, W. (1992) Markers for the diagnosis and monitoring of renal tubular lesions. Clin. Nephrol. 38(Suppl 1), s3-7.
16. Herget-Rosenthal, S., Poppen, D., Hüsing, J., Marggraf, G., Pietruck, F., Jakob, H. G., Philipp, T. and Kribben, A. (2004) Prognostic value of tubular proteinuria and enzymuria in nonoliguric acute tubular necrosis. Clin. Chem. 50, 552-558.
17. Horii, Y., Iwano, M., Hirata, E., Shiiki, M., Fujii, Y., Dohi, K. and Ishikawa, H. (1993) Role of interleukin-6 in the progression of mesan- gial proliferative glomerulonephritis. Kidney Int. 39(Suppl), S71-75.
18. Huerta-Alardín, A. L., Varon, J. and Marik, P. E. (2005) Bench-to- bedside review: Rhabdomyolysis - an overview for clinicians. Crit. Care 9, 158-169.
19. Ichimura, T., Bonventre, J. V., Bailly, V., Wei, H., Hession, C. A., Cate, R. L. and Sanicola, M. (1998) Kidney injury molecule-1 (KIM-1), a putative epithelial cell adhesion molecule containing a novel immunoglobulin domain, is up-regulated in renal cells after injury. J. Biol. Chem. 273, 4135-4142.
20. Isnard Bagnis, C., Deray, G., Baumelou, A., Le Quintrec, M. and Vanherweghem, J. L. (2004) Herbs and the kidney. Am. J. Kidney Dis. 44, 1-11.
21. Kharasch, E. D., Schroeder, J. L., Bammler, T., Beyer, R. and Srinouanprachanh, S. (2006) Gene expression profiling of nephrotoxicity from the sevoflurane degradation product fluoromethyl-2,2-difluoro-1-(trifluoromethyl)vinyl ether (compound A) in rats. Toxicol. Sci. 90, 419-431.
22. Kirtane, A. J., Leder, D. M., Waikar, S. S., Chertow, G. M., Ray, K. K., Pinto, D. S., Karmpaliotis, D., Burger, A. J., Murphy, S. A., Cannon, C. P., Braunwald, E. and Gibson, C. M; TIMI Study Group. (2005) Serum blood urea nitrogen as an independent marker of subsequent mortality among patients with acute coronary syndromes and normal to mildly reduced glomerular filtration rates. J. Am. Coll. Cardiol. 45, 1781-1786.
23. Kohli, H. S., Bhaskaran, M. C., Muthukumar, T., Thennarasu, K., Sud, K., Jha, V., Gupta, K. L. and Sakhuja. V. (2000) Treatment-relat- ed acute renal failure in the elderly: a hospital-based prospective study. Nephrol. Dial. Transplant. 15, 212-217.
24. Manor, S. M., Guillory, G. S. and Jain, S. P. (2004) Clopidogrel-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome after coronary artery stenting. Pharmacotherapy 24, 664-667.
25. Markowitz, G. S., Fine, P. L., Stack, J. I., Kunis, C. L., Radhakrishnan, J., Palecki, W., Park, J., Nasr, S. H., Hoh, S., Siegel, D. S. and D'Agati, V. D. (2003) Toxic acute tubular necrosis following treatment with zoledronate (Zometa). Kidney Int. 64, 281-289.
26. Markowitz, G. S. and Perazella MA. (2005) Drug-induced renal failure: a focus on tubulointerstitial disease. Clin. Chim. Acta 351, 31-47.
27. Mogensen, C. E. (1971) Urinary albumin excretion in early and longterm juvenile diabetes. Scand. J. Clin. Lab. Invest. 28, 101-109.
28. Nagai, J. and Takano, M. (2010) Molecular-targeted approaches to reduce renal accumulation of nephrotoxic drugs. Expert Opin. Drug Metab. Toxicol. 6, 1125-1138.
29. Naughton, C. A. (2008) Drug-induced nephrotoxicity. Am. Fam. Physician. 78, 743-750.
30. Nerlich, A. G., Schleicher, E. D., Wiest, I., Specks, U. and Timpl, R. (1994) Immunohistochemical localization of collagen VI in diabetic glomeruli. Kidney Int. 45, 1648-1656.
31. Nielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M. and Kjeldsen, L. (1996) Induction of NGAL synthesis in epithelial cells of human colorectal neoplasia and inflammatory bowel diseases. Gut 38, 414-420.
32. Nomura, S., Wills, A. J., Edwards, D. R., Heath, J. K. and Hogan, B. L. (1988) Developmental expression of 2ar (osteopontin) and SPARC (osteonectin) RNA as revealed by in situ hybridization. J. Cell Biol. 106, 441-450.
33. Ohlsson, S., Wieslander, J. and Segelmark, M. (2003) Increased circulating levels of proteinase 3 in patients with anti-neutrophilic cytoplasmic autoantibodies-associated systemic vasculitis in remission. Clin. Exp. Immunol. 131, 528-535.
34. Oldberg, A., Franzen, A. and Heinegard, D. (1986) Cloning and sequence analysis of rat bone sialoprotein (osteopontin) cDNA reveals an Arg-Gly-Asp cell-binding sequence. Proc. Natl. Acad. Sci. USA 83, 8819-8823.
35. Olyaei, A. J., de Mattos, A. M. and Bennett, W. M. (1999) Immunosuppressant-induced nephropathy: pathophysiology, incidence and management. Drug Saf. 21, 471-488.
36. Palmer, B. F. (2002) Renal dysfunction complicating the treatment of hypertension. N. Engl. J. Med. 347, 1256-1261.
37. Patarca, R., Freeman, G. J., Singh, R. P., Wei, F. Y., Durfee, T., Blattner, F., Regnier, D. C., Kojak, C. A., Mock, B. A., Morse, H. C., Jerrells, T. R. and Cantor, H. (1989) Structural and functional studies of the early T lymphocyte activation 1 (Eta-1) gene: Definition of a novel T cell dependent response associated with genetic resistance to bacterial infection. J. Exp. Med. 170, 145-161.
38. Perazella, M. A. (1999) Crystal-induced acute renal failure. Am. J. Med. 106, 459-465.
39. Perazella, M. A. (2005) Drug-induced nephropathy: an update. Expert Opin. Drug Saf. 4, 689-706.
40. Perneger, T. V., Whelton, P. K. and Klag, M. J. (1994) Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N. Engl. J. Med. 331, 1675-1679.
41. Pisoni, R., Ruggenenti, P. and Remuzzi, G. (2001) Drug-induced thrombotic microangiopathy: incidence, prevention and management. Drug Saf. 24, 491-501.
42. Prinsen, B. H., de Sain, van der Velden, M. G., Kaysen, G. A., Straver, H. W., van Rijn, H. J., Stellaard, F., Berger, R. and Rabelink, T. J. (2001) Transferrin synthesis is increased in nephrotic patients insufficiently to replace urinary losses. J. Am. Soc. Nephrol. 12, 1017-1025.
43. Rached E., Hoffmann, D., Blumbach, K., Weber, K., Dekant, W. and Mally, A. (2008) Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin A in vivo and in vitro. Toxicol. Sci. 103, 371-381.
44. Rodriguez-Iturbe, B. and Garcia Garcia, G. (2010) The role of tubulointerstitial inflammation in the progression of chronic renal failure. Nephron. Clin. Pract. 116, c81-c88.
45. Rossert, J. (2001) Drug-induced acute interstitial nephritis. Kidney Int. 60, 804-817.
46. Schaub, S., Wilkins, J. A., Antonovici, M., Krokhin, O., Weiler, T., Rush, D. and Nickerson, P. (2005) Proteomic-based identification of cleaved urinary beta2-microglobulin as a potential marker for acute tubular injury in renal allografts. Am. J. Transplant. 5, 729-738.
47. Schetz, M., Dasta, J., Goldstein, S. and Golper, T. (2005) Drug-induced acute kidney injury. Curr. Opin. Crit. Care 11, 555-565.
48. Schnellmann, R.G. and Kelly, K.J. (1999). Pathophysiology of nephrotoxic acute renal failure, in atlas of diseases of the kidney vol 1. (R. W. Schrier, Ed.), pp 15.1-15.14. Blackwell Science (Wash DC) Ltd., Oxford.
49. Schoolwerth A. C., Sica, D. A., Ballermann, B. J. and Wilcox, C. S.; Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. (2001) Renal considerations in angiotensin converting enzyme inhibitor therapy: a statement for healthcare professionals from the Council on the Kidney in Cardiovascular Disease and the Council for High Blood Pressure Research of the American Heart Association. Circulation 104, 1985-1991.
50. Schurek, H. J., Neumann, K. H., Flohr, H., Zeh, M. and Stolte, H. (2000) Diagnostic and prognostic significance of proteinuria selectivity index in glomerular diseases. Clin. Chim. Acta 297, 73-83.
51. Shao, C., Li, M., Li, X., Wei, L., Zhu, L., Yang, F., Jia, L., Mu, Y., Wang, J., Guo, Z., Zhang, D., Yin, J., Wang, Z., Sun, W., Zhang, Z. and Gao, Y. (2011) A tool for biomarker discovery in the urinary proteome: a manually curated human and animal urine protein biomarker database. Mol. Cell Proteomics 10, M111.010975.
52. Shiraga, H., Min, W., Van Dusen, W.J., Clayman, M.D., Miner, D., Terrell, C. H., Sherbotie, J. R., Foreman, J. W., Przysiecki, C., Neilson, E. G. and Hoyer, J. R. (1992) Inhibition of calcium oxalate crystal growth in vitro by uropontin: Another member of the aspartic acidrich protein superfamily. Proc. Natl. Acad. Sci. USA 89, 426-430.
53. Vaidya, V. S., Ferguson, M. A. and Bonventre, J. V. (2008) Biomarkers of acute kidney injury. Annu. Rev. Pharmacol. Toxicol. 48, 463-493.
54. Vaidya, V. S., Ramirez, V., Ichimura, T., Bobadilla, N. A. and Bonventre, J. V. (2006) Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal. Physiol. 290, F517-529.
55. Wada, T., Yokoyama, H., Tomosugi, N., Hisada, Y., Ohta, S., Naito, T., Kobayashi, K., Mukaida, N. and Matsushima, K. (1994) Detection of urinary interleukin-8 in glomerular diseases. Kidney Int. 46, 455-460.
56. Wu, Y., Yang, L., Su, T., Wang, C., Liu, G. and Li, X. M. (2010) Pathological significance of a panel of urinary biomarkers in patients with drug-induced tubulointerstitial nephritis. Clin. J. Am. Soc. Nephrol. 5, 1954-1959.
57. Xu, S. Y., Pauksen, K. and Venge, P. (1995) Serum measurements of human neutrophil lipocalin (HNL) discriminate between acute bacterial and viral infections. Scand. J. Clin. Lab. Invest. 55, 125-131.
58. Zager, R. A. (1997) Pathogenetic mechanisms in nephrotoxic acute renal failure. Semin. Nephrol. 17, 3-14.